...
首页> 外文期刊>Nature Microbiology >HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy
【24h】

HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy

机译:抑制抗逆转录病毒治疗尿道尿道巨噬细胞的HIV-1水库

获取原文
获取原文并翻译 | 示例

摘要

Human immunodeficiency virus type 1 (HIV-1) eradication is prevented by the establishment on infection of cellular HIV-1 reservoirs that are not fully characterized, especially in genital mucosal tissues (the main HIV-1 entry portal on sexual transmission). Here, we show, using penile tissues from HIV-1-infected individuals under suppressive combination antiretroviral therapy, that urethral macrophages contain integrated HIV-1 DNA, RNA, proteins and intact virions in virus-containing compartment-like structures, whereas viral components remain undetectable in urethral T cells. Moreover, urethral cells specifically release replication-competent infectious HIV-1 following reactivation with the macrophage activator lipopolysaccharide, while the T-cell activator phytohaemagglutinin is ineffective. HIV-1 urethral reservoirs localize preferentially in a subset of polarized macro-phages that highly expresses the interleukin-1 receptor, CD2O6 and interleukin-4 receptor, but not CD163. To our knowledge, these results are the first evidence that human urethral tissue macrophages constitute a principal HIV-1 reservoir. Such findings are determinant for therapeutic strategies aimed at HIV-1 eradication.
机译:通过在没有完全表征的细胞HIV-1储层感染的情况下,防止了人类免疫缺陷病毒类型1(HIV-1)根除,特别是在生殖器粘膜组织(性传播中主要的HIV-1入口门户网站)。在这里,我们展示了来自抑制组合抗逆转录病毒治疗的HIV-1感染个体的阴茎组织,尿道巨噬细胞含有含有病毒的室内结构的集成的HIV-1 DNA,RNA,蛋白质和完整的病毒群,而病毒组分保留尿道T细胞中未检测到。此外,尿道细胞特异性地释放了与巨噬细胞活化剂脂多糖的再活化后的复制态感染HIV-1,而T细胞活化剂Phytohaemagglutinin是无效的。 HIV-1尿道储层优先定位在极化宏观噬菌体的子集中,高表达白细胞介素-1受体,CD2O6和白细胞介素-4受体,但不是CD163。据我们所知,这些结果是第一个证据表明人尿道组织巨噬细胞构成了主要的HIV-1水库。这些发现是针对旨在HIV-1根除的治疗策略的决定因素。

著录项

  • 来源
    《Nature Microbiology 》 |2019年第4期| 共12页
  • 作者单位

    Cochin Inst Dept Infect Immun &

    Inflammat CNRS UMR8104 Lab Mucosal Entry HIV &

    Mucosal Immun 1 Paris France;

    Cochin Inst Dept Infect Immun &

    Inflammat CNRS UMR8104 Lab Mucosal Entry HIV &

    Mucosal Immun 1 Paris France;

    Cochin Inst Dept Infect Immun &

    Inflammat CNRS UMR8104 Lab Mucosal Entry HIV &

    Mucosal Immun 1 Paris France;

    INSERM U1016 Paris France;

    Rutgers State Univ Publ Hlth Res Inst Rutgers New Jersey Med Sch Newark NJ USA;

    Cochin Inst Dept Infect Immun &

    Inflammat CNRS UMR8104 Lab Mucosal Entry HIV &

    Mucosal Immun 1 Paris France;

    Cochin Inst Dept Infect Immun &

    Inflammat CNRS UMR8104 Lab Mucosal Entry HIV &

    Mucosal Immun 1 Paris France;

    INSERM U1016 Paris France;

    INSERM U1016 Paris France;

    Cochin Inst Dept Infect Immun &

    Inflammat CNRS UMR8104 Lab Mucosal Entry HIV &

    Mucosal Immun 1 Paris France;

    Cochin Inst Dept Infect Immun &

    Inflammat CNRS UMR8104 Lab Mucosal Entry HIV &

    Mucosal Immun 1 Paris France;

    INSERM U1016 Paris France;

    Cochin Inst Dept Infect Immun &

    Inflammat CNRS UMR8104 Lab Mucosal Entry HIV &

    Mucosal Immun 1 Paris France;

    INSERM U1016 Paris France;

    Ambroise Pare Hosp Hematol &

    Immunol Serv Boulogne France;

    Rutgers State Univ Publ Hlth Res Inst Rutgers New Jersey Med Sch Newark NJ USA;

    INSERM U1016 Paris France;

    St Louis Hosp Plast Reconstruct &

    Aesthet Surg Dept Paris France;

    St Louis Hosp Plast Reconstruct &

    Aesthet Surg Dept Paris France;

    INSERM U1016 Paris France;

    Cochin Inst Dept Infect Immun &

    Inflammat CNRS UMR8104 Lab Mucosal Entry HIV &

    Mucosal Immun 1 Paris France;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 微生物学 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号